An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
Faculty of Medicine Tanta University, Tanta, Egypt
King Abdullah Specialist Children Hospital (KASCH), Riyadh, Saudi Arabia
KRL Hospital, Islamabad, Pakistan
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
Cardiosurgery departments with intensive care block, Kyiv, Ukraine
Anesthesia department Medical Network Dobrobut, Kyiv, Ukraine
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.